Explore the Global Implantable Drug Eluting Devices Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Implantable Drug Eluting Devices Market

Key Insight

Demand for implantable drug eluting devices will increase through 2036, with contraceptive drug eluting devices at a 39.4% share in 2026 as the leading product segment. The market was valued at USD 15.20 billion in 2025 and is expected to reach USD 28.85 billion by 2036, creating an incremental opportunity of USD 12.74 billion.

May 20, 2026

Anurag Sharma

326 Pages

Cite this Report

Implantable Drug Eluting Devices Market

https://www.futuremarketinsights.com/reports/implantable-drug-eluting-devices-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Abbott Laboratories
Alimera Sciences Inc
Allergan plc
BlackRock
Biotronik SE & Co. KG
Bausch
Bayer
Boston Scientific
The Vanguard Group
Lomb
Medtronic plc
Merck KGaA
REVA Medical
SurModics Inc
Titan Pharmaceuticals

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Implantable Drug Eluting Devices Market

Key Players

Similar Industry Reports